Lou Z, Wang X, Hu C, Liu W, Ji Y. Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer. Pak J Med Sci [Internet]. 2024Jun.28 [cited 2024Jul.3];40(7). Available from: https://pjms.org.pk/index.php/pjms/article/view/9681